January 2022 - Page 10 of 27

ThursdayJan 20, 2022 12:12 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at Virtual Investor 2022 Top Picks Conference

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system (“CNS”), today announced that its CEO John Climaco will participate in the Virtual Investor 2022 Top Picks Conference at 11:00 a.m. ET on Wednesday, Jan. 26, 2022. As part of the virtual event, the company will provide a corporate presentation followed by an interactive Q&A session. In addition to the moderated portion, investors and attendees will have the opportunity to submit questions live during the event or in advance of the conference via www.VirtualInvestorCo.com.…

ThursdayJan 20, 2022 12:11 pm

Friendable Inc. (FDBL) Shares Fan Pass Live Milestones and Major Acquisition, Plans for Upcoming Year

President and CTO Dean Rositano was invited to be a new member of the prestigious Rolling Stone Culture Council – an invitation-only network of leaders who are on the cutting edge of culture, community, and the Rolling Stone brand Artist Republik will join Fan Pass Live as a Friendable Company, increasing the number of artists on the platform CEO and Co-Founder Robert Rositano Jr. explained that one of the company’s main goals has always been to test multiple entry points to gain exposure in the music industry for artists and fans alike Mobile technology and marketing company Friendable (OTC: FDBL)…

ThursdayJan 20, 2022 11:29 am

QualityStocksNewsBreaks – PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) Launches New YouTube Series – ‘Medically Speaking’

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced the launch of its new YouTube series entitled “Medically Speaking,” designed to enhance plant-based education and equip consumers with the necessary knowledge to achieve their plant-based goals. The new series will center around informative conversations with the PlantX medical advisory board on plant-based topics. Beyond providing evidence-based information to clarify potential questions and knowledge gaps in the plant-based space, Medically Speaking also aims to offer creative solutions to overcoming plant-based challenges as approved and discussed by trusted health care professionals. “We have seen a tremendous global shift to plant-based diets…

ThursdayJan 20, 2022 10:51 am

QualityStocksNewsBreaks – Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) (FRA: 7CR) Welcomes Four New Operators, on Track for Record 2022

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FRA: 7CR) is a propriety software-as-a-service (“SaaS”) technology company delivering mobile live dealer technology (VegasLounge(TM)) to online gaming operators globally. The company announced that it has gone live with four new operators, now offering Playgon's Live Dealer games to global clients. This brings Playgon to a total of 30 operators utilizing the company's technology, with an additional five operators in the queue at various stages of onboard testing. “We are very pleased to welcome four new operators into the Playgon family. They are impressed with our technology and are already contributing to player activity…

WednesdayJan 19, 2022 2:04 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Participate in Innovations and Advancements in the CBD Market Webinar

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables and services to the worldwide food and beverage, biotherapeutics and personal wellness industries, among others, today announced its participation in the Jan. 20, 2022, Innovations and Advancements in the CBD Market webinar. The real-time, interactive “fireside chat,” sponsored by FORCE Family Office, will feature three companies that have released or are about to release important, innovative products and services and/or advancements in the CBD space. Pressure BioSciences, which is planning for a mid-2022 release of its revolutionary Ultra Shear Technology(TM) (“UST”(TM))…

WednesdayJan 19, 2022 1:19 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Standing Distinct by Creating Sophisticated, Luxurious Crossover EV-SUV

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, aims to set itself apart from the rest of the automotive pack through the creation of a sophisticated and luxurious crossover EV-SUV, a vehicle that has been meticulously designed by the creators of the famed Rolls Royce Ghost, all while boasting Tesla-rivaling performance. Mullen Automotive debuted its Mullen FIVE EV Crossover at the recent LA Auto Show, where it received the show’s ZEVA(R) Award for top all-electric SUV, beating out entries from the likes of Lincoln and Rivian. “The Mullen FIVE, starting at $55,000, is set to come equipped with…

WednesdayJan 19, 2022 1:02 pm

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Strengthening ‘Emerging Best-in-Class Position’ in Evolving Industry

Cybin (NYSE American: CYBN) (NEO: CYBN), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, recently received a notice of allowance from the U.S. Patent and Trademark Office (“USPTO”). The notice was regarding Cybin’s patent application connected to its investigational deuterated psychedelic tryptamine compound, CYB004, for the potential treatment of anxiety disorders. “The receipt of this notice of allowance from the USPTO represents an important milestone in expanding our intellectual property portfolio progressing psychedelics to therapeutics for the countless patients in need, and strongly demonstrates the company’s dedication to the discovery and development of differentiated psychedelic-based…

WednesdayJan 19, 2022 12:49 pm

QualityStocksNewsBreaks – Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) (FRA: 7CR) on Track for Continued Growth

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FRA: 7CR), a proprietary software-as-a-service (“SaaS”) company that delivers live dealer mobile technology to global online gaming operators, is aligning with emerging technology trends and poised for continued growth in 2022. “Technological innovation delivers enhanced graphics, virtual reality (‘VR’), increased security and cryptocurrency payment options that benefit the iGaming industry. PLGNF, with its proprietary cloud-based technology, offers operators turnkey solutions that leverage technological advancements to deliver authentic gaming experiences to a growing user base,” a recent article reads. “PLGNF is in complete alignment with advancements in iGaming technology by providing a multitenant gateway that…

WednesdayJan 19, 2022 12:30 pm

QualityStocksNewsBreaks – SPYR Inc. (SPYR) Announces Retention of Investor, PR Partner

SPYR (OTCQB: SPYR), dba SPYR Technologies, a technology company, has retained Emerging Markets Consulting LLC (“EMC”) to provide investor and public relations services. SPYR’s subsidiary, Applied Magix Inc., develops and resells Apple(R) ecosystem-compatible products in the growing multibillion-dollar IoT smart-home and connected car markets. According to the announcement, EMC specializes in assisting small and mid-sized public companies strengthen their brands and grow market share while also increasing awareness among the institutional and retail investment community. “After meeting their talented team, I am excited to be working with EMC," said SPYR Technologies CEO Tim Matula in the press release. “EMC's representation will…

WednesdayJan 19, 2022 12:09 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Rare Cannabinoid Product Portfolio to Launch CBT

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced that it has launched B2B sales of the rare cannabinoid cannabicitran (“CBT”) into the health and wellness sector. According to the update, CBT is the first of several new product launches the company has planned for the first half of 2022. “We are delivering on our objective to launch additional rare cannabinoids in early 2022 in response to inbound demand. By midyear, we expect to have at least four rare cannabinoids available for the health and wellness markets, positioning us as a…

Site Search

Company Search

Month: January 2022